Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

Nutex Health, Inc.NASDAQ: NUTX

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables declines year over year

Q1 FY2026 accounts receivables of $20.48M (cash outflow) fell 67.6% year over year, ahead of the -80.1% change in trailing-twelve-month accounts receivables.

Context

  • Accounts receivables amounted to 10.2% of revenue in FY2025, down 25.9 pp from a year earlier.
  • Accounts receivables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -67.6% holds above the trailing-twelve-month pace of -80.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$20.48M-125.1% QoQ
Last fiscal yearDec 2025
-$89.32M-48.5% YoY
LTMMar 2026
-$46.51M-80.1% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-67.6%——
1 year-48.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(89.32M) USD
Year-over-year change
+48.5%

Accounts Receivables vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 accounts receivables of $46.51M is the 5th largest of the 11 companies compared; the peer median is $14.31M.
  • Its year-over-year change of -80.1% is the 8th highest of 10, against a peer median of +103.9%.
  • Accounts receivables amounts to 5.3% of revenue for NUTX, versus a peer median of 0.7%.
NUTX Competitors Peer median
Accounts Receivables for NUTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UHSUniversal Health Services, Inc.LTM Jun 2026$363.26M +297.2%+7.2%2.0%
ARDTArdent Health Partners, LLCLTM Mar 2026$89.9M +276.1%—1.4%
EHCEncompass Health CorporationLTM Jun 2026$62.9M +362.5%-3.5%1.0%
THCTenet Healthcare CorporationLTM Jun 2026$53M -125.5%—0.2%
NUTXNutex Health, Inc.LTM Mar 2026$46.51M -80.1%—5.3%
SGRYSurgery Partners, Inc.LTM Sep 2026$45.7M -6.0%+15.1%1.4%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$28.63M +47.8%+23.4%1.2%
CYHCommunity Health Systems, Inc.LTM Mar 2026$6M +103.9%+65.1%0.0%
INNVInnovAge Holding Corp.LTM Mar 2026$4.32M +141.8%—0.5%
AGLAgilon Health, Inc.LTM Mar 2026$0 ——0.0%
ASTHAstrana Health, Inc.LTM Mar 2026$0 -100.0%-40.5%0.0%
Peer median (excluding NUTX) $14.31M+103.9%+11.1%0.7%

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income168.53M(432.74M)(43.42M)95.27M180.36M
Depreciation & Amortization7.66M13.13M17.59M18.97M20.53M
Deferred Income Tax05M(5.71M)(13.13M)17.08M
Stock-Based Compensation0189.58K2.84M16.63M117M
Change in Working Capital2.75M64.32M(1.66M)(104.4M)(87.74M)
Accounts Receivables(6.62M)58.08M(4.58M)(173.41M)(89.32M)
Inventory(1.09M)(719.11K)142.7K540.77K(16K)
Accounts Payables6.27M9.69M(2.25M)(10.72M)37.85M
Other Working Capital4.2M(2.73M)5.03M79.19M(36.26M)
Other Non-Cash Items(5.51M)400.71M31.62M9.81M902K
Operating Cash Flow173.43M50.61M1.26M23.15M248.13M
Capital Expenditures(36.93M)(14.63M)(9.5M)(2.3M)(2.53M)
Acquisitions (Net)(48.85K)10.3M(1.74M)(361.33K)0
Purchases of Investments00000
Sales of Investments00001.6M
Other Investing Activities0000(4.31M)
Investing Cash Flow(36.98M)(4.34M)(11.24M)(2.67M)(5.24M)
Debt Repayment(3.22M)(5.59M)2.65M(7.4M)(19.44M)
Common Stock Issued04.76M09.2M0
Common Stock Repurchased0000(5M)
Dividends Paid(144.34M)(51.23M)(5.21M)(6.44M)(74.28M)
Other Financing Activities21.71M3.93M298.03K5.73M767K
Financing Cash Flow(125.85M)(48.13M)(2.27M)1.09M(97.95M)
Effect of Forex Changes00000
Net Change in Cash10.6M(1.86M)(12.25M)21.58M144.93M
Free Cash Flow136.51M35.97M(8.24M)20.85M245.6M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.